Cargando…

The Role of Dopamine Replacement on the Behavioural Phenotype of Parkinson’s Disease

Objectives: The pharmacotherapy of Parkinson’s disease (PD) is often challenging as clinicians have to find a favourable balance between the efficacy on motor symptoms and side effect profiles of different dopaminergic medications. We aimed to assess the available evidence on the role of dopamine ag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alobaidi, Hajar, Pall, Hardev
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2013
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214930/ https://www.ncbi.nlm.nih.gov/pubmed/22713412 http://dx.doi.org/10.3233/BEN-2012-120265

Ejemplares similares

The degeneration and replacement of dopamine cells in Parkinson’s disease: the role of aging
por: Rodriguez, Manuel, et al.
Publicado: (2014)

The Role of Dopamine and Glutamate Modulation in Huntington Disease
por: Mittal, Sumeer K., et al.
Publicado: (2013)

Polymeric nanoparticles for dopamine and levodopa replacement in Parkinson's disease
por: Alabrahim, Obaydah Abd Alkader, et al.
Publicado: (2022)

Replacing Dopamine Neurons in Parkinson’s Disease: How did it happen?
por: Björklund, Anders, et al.
Publicado: (2017)

Differential Effects of Parkinson's Disease and Dopamine Replacement on Memory Encoding and Retrieval
por: MacDonald, Alex A., et al.
Publicado: (2013)

Speech-based characterization of dopamine replacement therapy in people with Parkinson’s disease
por: Norel, R., et al.
Publicado: (2020)

Role of dopamine in the pathophysiology of Parkinson’s disease
por: Zhou, Zhi Dong, et al.
Publicado: (2023)

Dopamine Replacement Therapy, Learning and Reward Prediction in Parkinson’s Disease: Implications for Rehabilitation
por: Ferrazzoli, Davide, et al.
Publicado: (2016)

Bioinspired Theranostic Coordination Polymer Nanoparticles for Intranasal Dopamine Replacement in Parkinson’s Disease
por: García-Pardo, Javier, et al.
Publicado: (2021)

Normalization effect of dopamine replacement therapy on brain functional connectome in Parkinson's disease
por: Wu, Chenqing, et al.
Publicado: (2023)

Effects of dopamine on reinforcement learning in Parkinson’s disease depend on motor phenotype
por: van Nuland, Annelies J, et al.
Publicado: (2020)

Gambling Disorder during Dopamine Replacement Treatment in Parkinson's Disease: A Comprehensive Review
por: Pirritano, Domenico, et al.
Publicado: (2014)

Evaluation of the Role of LRRK2 Gene in Parkinson’s Disease in an East Indian Cohort
por: Sadhukhan, Tamal, et al.
Publicado: (2012)

Dopamine Replacement Modulates Oscillatory Coupling Between Premotor and Motor Cortical Areas in Parkinson's Disease
por: Herz, Damian Marc, et al.
Publicado: (2014)

Dopamine Receptors and Parkinson's Disease
por: Hisahara, Shin, et al.
Publicado: (2011)

Intracerebroventricular dopamine for Parkinson's disease
por: Devos, David, et al.
Publicado: (2017)

The Use of Machine Learning to Predict Late Arrivals at the Adult Outpatient Department
por: Aldhoayan, Mohammed D, et al.
Publicado: (2023)

Drug and Disease Effects in Parkinson's Psychosis: Revisiting the Role of Dopamine
por: Dave, Sonali, et al.
Publicado: (2019)

The role of tyrosine hydroxylase–dopamine pathway in Parkinson’s disease pathogenesis
por: Zhou, Zhi Dong, et al.
Publicado: (2022)

Dual Task Performance in Parkinson’s Disease
por: Foley, Jennifer A., et al.
Publicado: (2013)

Parkinson’s Disease Protects Against Smoking?
por: Allam, Mohamed Farouk, et al.
Publicado: (2004)

The treatment of Parkinson's disease with dopamine agonists
por: Konta, Brigitte, et al.
Publicado: (2008)

Impaired dopamine release in Parkinson’s disease
por: Cramb, Kaitlyn M L, et al.
Publicado: (2023)

The Pathophysiology of Impulse control Disorders in Parkinson Disease
por: Balarajah, Sharmili, et al.
Publicado: (2013)

Decision-Making Impairments in Patients with Parkinson’s Disease
por: Brand, Matthias, et al.
Publicado: (2004)

Oxidative Stress and Neuroinflammation in Parkinson’s Disease: The Role of Dopamine Oxidation Products
por: Chakrabarti, Sasanka, et al.
Publicado: (2023)

Impulsive-compulsive behaviour in early Parkinson’s disease is determined by apathy and dopamine receptor D3 polymorphism
por: Theis, Hendrik, et al.
Publicado: (2023)

Apolipoprotein E Genotypes in Mexican Patients with Parkinson's Disease
por: Gallegos-Arreola, M.P., et al.
Publicado: (2009)

DJ-1 Variants in Indian Parkinson’s Disease Patients
por: Sadhukhan, Tamal, et al.
Publicado: (2012)

A Role for Nonapeptides and Dopamine in Nest-Building Behaviour
por: Hall, Z J, et al.
Publicado: (2015)

Dopamine-Induced Nonmotor Symptoms of Parkinson's Disease
por: Park, Ariane, et al.
Publicado: (2011)

Dopamine Agonist Therapy in Advanced Parkinson’s Disease
por: Reichmann, Heinz
Publicado: (2009)

The effects of dopamine on digit span in Parkinson’s disease
por: Warden, Clara, et al.
Publicado: (2016)

Dopamine and Levodopa Prodrugs for the Treatment of Parkinson’s Disease
por: Haddad, Fatma, et al.
Publicado: (2017)

Impaired dopamine metabolism in Parkinson’s disease pathogenesis
por: Masato, Anna, et al.
Publicado: (2019)

Strategies for the Treatment of Parkinson’s Disease: Beyond Dopamine
por: Iarkov, Alexandre, et al.
Publicado: (2020)

Progressive Micrographia Shown in Horizontal, but not Vertical, Writing in Parkinson’s Disease
por: Ma, Hui-Ing, et al.
Publicado: (2013)

Pergolide Mesilate May Improve Fatigue in Patients with Parkinson’s Disease
por: Abe, Kazuo, et al.
Publicado: (2002)

Auditory Evoked P300 Potential in Patients With Parkinson’s Disease
por: Rajendran, Dhivya, et al.
Publicado: (2023)

Role of Dopamine β Hydroxylase (DBH) in Parkinson's disease patients of Indian population
por: Ghosh, Arunibha, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_iga2kljg3odlcb3eguqmgrk8l6